Bristol could seek FDA’s OK on 3 cancer drugs
From the Associated Press
Bristol-Myers Squibb Co. said it would submit at least one new cancer drug for approval next year and might file a total of three with the Food and Drug Administration.
The company plans to file a marketing application on Ixabepilone for breast cancer next year. It will file applications on Ipilimumab for melanoma and Vinflunine for bladder cancer in late 2007 or 2008.
